Cargando…
Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
Hyoscine butylbromide, also known as hyoscyamine or scopolamine, and sold under the trade name Buscopan, is an antimuscarinic agent commonly used to induce smooth muscle relaxation and reduce spasmodic activity of the gastrointestinal (GI) tract during endoscopic procedures. However, the balance bet...
Autores principales: | Forbes, Nauzer, Frehlich, Levi, Borgaonkar, Mark, Leontiadis, Grigorios I, Tse, Frances |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643672/ https://www.ncbi.nlm.nih.gov/pubmed/34877465 http://dx.doi.org/10.1093/jcag/gwab038 |
Ejemplares similares
-
COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020
por: Tse, Frances, et al.
Publicado: (2020) -
A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative Radiotherapy
por: Slevin, Finbar, et al.
Publicado: (2021) -
COVID-19: Framework for the Resumption of Endoscopic Activities From the Canadian Association of Gastroenterology
por: Ménard, Charles, et al.
Publicado: (2020) -
Hyoscine butylbromide induced psychosis: A case report
por: Lageju, Nimesh, et al.
Publicado: (2022) -
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021)